Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines

Introduction  Hormonal status and HER2 expression are valuable biomarkers and dictate the management of the patients diagnosed with invasive breast cancer (IBC). It is crucial to identify the patients who truly respond to anti-HER2 targeted therapy. Updated 2018 American Society of Clinical Oncology...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarjun, B. R., Parikh, Biren, Patel, Manaswi Nareshkumar, Trivedi, Pina J., Patel, Dharmesh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902087/
https://www.ncbi.nlm.nih.gov/pubmed/36756105
http://dx.doi.org/10.1055/s-0042-1751052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902087/
https://www.ncbi.nlm.nih.gov/pubmed/36756105
http://dx.doi.org/10.1055/s-0042-1751052

Ejemplares similares